fbpx
close read more
News

Suspension of the Marketing Authorisations and withdrawal of fenspiride based drugs (Pneumorel and Eurespal) from the market

08/02/2019

Suspension of the Marketing Authorisations and withdrawal of fenspiride based drugs (Pneumorel and Eurespal) from the market

For France for more information click here.

For other countries, please contact the local Servier subsidiary in your country.

Last news

News
23/06/2022
Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
News
15/06/2022
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
News
01/06/2022
Patient associations’ perception of pharmaceutical companies: Servier is making progress!